Efficacy and Safety of Antioxidant Supplementation in Women With Endometriosis: a Systematic Review of Randomized Controlled Trials
Year: 2026
Type: review
Abstract: Background: Endometriosis affects ~10% of reproductive-age women, causing pain and infertility. Limitations of conventional therapies have driven interest in targeting oxidative stress, though clinical evidence on antioxidant efficacy and safety remains inconsistent. Aim: To evaluate the efficacy, safety, and biomarker impact of antioxidant supplementation in women with endometriosis based on randomized controlled trials (RCTs). Materials and Methods: Following PRISMA guidelines, a systematic PubMed search identified 119 unique records, screened via Rayyan based on PICOS criteria. Eligible studies were RCTs evaluating antioxidant supplementation versus control in adult women with confirmed endometriosis. Ultimately, 26 RCTs met all inclusion criteria. Results: Selected antioxidants significantly attenuated oxidative and inflammatory markers (e.g., reduced hs-CRP with vitamin D; lower IL-1$\beta$, TNF-α, and MDA with astaxanthin/nanocurcumin; suppressed MMP-2/9 and VEGF with resveratrol). Clinically, vitamins C/E, nanocurcumin, selenium, and vitamin D reduced pelvic pain, whereas melatonin, fish oil, and resveratrol showed mixed or no benefit. Quality of life (EHP-30) did not improve vs. placebo, though adjunctive curcumin enhanced generic quality of life and sexual function. Astaxanthin and nanocurcumin increased mature oocyte yield and embryo quality during ART, but without significant improvements in clinical pregnancy rates. Conclusions: Antioxidants effectively modulate oxidative, inflammatory, and angiogenic pathways in endometriosis. However, biochemical improvements do not consistently translate into clinical benefits regarding pain, quality of life, or pregnancy rates. Due to high study heterogeneity and inconsistent safety data, antioxidants should be considered investigational adjunctive options rather than routine treatment.
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $100
OpenAlex ID: W7233551375
